- The AIRNA Team
- Board of Directors
- Founders
- Investors
A team that is passionate about restoring patient health.
Aindrila_Chatterjee
Senior Scientist
Amy Mendel
Chief Legal Officer
Devyn Smith
Arbor Bio
Andrea Armstrong
Interim Chief People Officer
Anindya Sen
Vice President, Preclinical Development
Thorsten Stafforst
Founder
Christopher Volkert
Research Associate
Eric Moessinger
ND Capital
Jin Billy Li
Founder
Daniella Mizurini
Senior Scientist
Josh Brumm
Forbion
Dirk Lindenblatt
Scientist
Elena Poser
Principal Scientist
Elisangela Bressan
Senior Scientist
Eva-Maria Duerr
Scientist
Fernanda Sachenbacher
Senior Scientist
Inga Jarmoskaite
Senior Scientist
Juri Eyberg
Scientist
One Airna
Kaiko Kunii
In Vivo Pharmacologist
Kat Feldmann
Senior Executive Assistant
Konstantin Licht
Senior Scientist
“RNA editing opens a world of possibilities never seen before”
Thorsten Stafforst, Founder
Kris Elverum
President and CEO
Kris Elverum
President and CEO
“RNA editing has unique potential to make transformative medicines for many patients”
Rodger Novak
Lena Fischer
Sr. Director Finance & Operations
Rodger Novak
Board Chair
Li-Hao Chang
Scientist
Sean Kendall
ARCH Venture Partners
Luise Stafforst
Lab manager
Maegan Brunelle
Accounting Manager
Manvi Upadhyay
Senior Research Associate
Martina Buttschardt
Research Associate
Namita Bisaria
Vice President, Strategy & Program Management
Negin Namazian
Sr. Research Associate
Patrick Foster
Vice President of CMC
Paul Vogel
VP Research & Managing Director
Paul Vogel
VP Research & Managing Director
Thorsten Stafforst
Founder
Peter Borsos
Research Associate
Piotr Putaj
Associate Director
Rewati Tappu
Senior Scientist
Robert Altshuler
Head of Computational Biology
Sriram Sathy
CSO
Sruthi V. Hindupur
Scientist
Stephen Su
Senior Director, Target Validation
Tobias Merkle
Senior Director, Platform Development
Tobias Merkle
Senior Director, Platform Development
Veronica Giachin
Research Associate
Victor De Jesus
Associate Scientist